Current Edition

The Global Regulatory Landscape for Clinical Trials Considering the COVID-19 Pandemic

The outbreak of COVID-19 created unprecedented circumstances for the conduct of clinical trials across the world. While the industry has experienced challenging conditions in managing research before, this type of crisis was typically local and short-term.
Marcelina Rybiańska and Aman Khera at Worldwide Clinical Trials take a look at the global regulatory landscape for clinical trials during COVID-19.